17-OH progesterone : Chapter XV.4
21-hydroxylase deficiency : Chapter XIII.11
21-hydroxylase deficiency : Chapter XV.4
abdominal abscess : Chapter X.11
abdominal pain : Chapter IX.2
abdominal pain : Chapter X.3
abducens nerve (CN VI) : Chapter XVIII.1
ABO incompatibility : Chapter III.2
ABO isoimmunization : Chapter III.2
abrasions : Chapter X.1
abruptio placentae : Chapter III.3
abscess : Chapter VI.2
abscess : Chapter VI.13
abscess : Chapter VI.34
abscess : Chapter X.11
absence seizure : Chapter XVIII.4
absence status epilepticus : Chapter XVIII.5
absolute risk reduction : Chapter XXII.2
accommodation reflex : Chapter XVIII.1
ACE inhibitors : Chapter VII.1
acetaminophen : Chapter VI.3
acetaminophen : Chapter XIV.9
acetaminophen overdose : Chapter XIV.10
Achilles reflex : Chapter XVIII.1
Achilles tendonitis : Chapter XIX.8
achondroplasia : Chapter I.2
achondroplasia : Chapter IV.1
achondroplasia : Chapter IV.2
acidosis : Chapter VIII.1
acidosis : Chapter XIV.1
acidosis : Chapter XIV.3
acidosis : Chapter XIV.9
acne : Chapter XXI.2
acoustic neuroma : Chapter XVIII.11
acrocyanosis : Chapter III.7
acromioclavicular injury : Chapter XIX.7
ACTH : Chapter XV.4
ACTH : Chapter XVIII.12
activated charcoal : Chapter XIV.9
activated charcoal : Chapter XIV.10
active immunization : Chapter I.4
acute chest syndrome : Chapter XI.3
acute endocarditis : Chapter VII.5
acute glomerulonephritis : Chapter XIII.1
acute lymphoblastic leukemia : Chapter XII.2
acute lymphocytic leukemia : Chapter XII.2
acute osteomyelitis : Chapter XIX.4
acute otitis media (AOM) : Chapter VI.6
acute respiratory infection (ARI) : Chapter VI.11
acute retroviral syndrome : Chapter VI.20
acute rheumatic fever : Chapter VII.4
acute scrotum : Chapter XIII.10
acyanotic congenital heart disease : Chapter VII.2
acyclovir : Chapter VI.15
acyclovir : Chapter VI.21
acyclovir : Chapter XXI.6
ADD : Chapter I.8
ADD : Chapter I.10
addiction : Chapter XX.3
Addisonian crisis : Chapter XIII.11
Addison's disease : Chapter XV.4
adenoma sebaceum : Chapter XVIII.1
adenoma sebaceum : Chapter XVIII.12
adenosine deaminase deficiency : Chapter V.5
adenovirus : Chapter VI.1
adenovirus : Chapter VI.9
adenovirus : Chapter VI.10
adenovirus : Chapter VI.22
ADH : Chapter XV.5
ADHD : Chapter I.8
ADHD : Chapter I.10
ADHD : Chapter XV.3
adjusted mid-parental height : Chapter XV.3
adolescent gynecology : Chapter XX.7
adrenal insufficiency : Chapter XV.4
adrenal cortex : Chapter V.4
adrenal insufficiency : Chapter III.8
adrenarche : Chapter XX.1
African sleeping sickness : Chapter VI.31
afterload : Chapter XIV.2
aganglionosis : Chapter IX.9
AIDS : Chapter VI.20
air contrast enema : Chapter X.4
airway : Chapter VIII.10
airway : Chapter XIV.4
airway : Chapter XIV.8
alanine aminotransferase (ALT) : Chapter IX.5
albendazole : Chapter VI.31
albumin : Chapter XIV.2
albuminocytologic dissociation : Chapter XVIII.7
albuterol : Chapter V.2
albuterol : Chapter VIII.2
albuterol : Chapter VIII.4
albuterol : Chapter XIV.2
albuterol : Chapter XV.4
alcohol : Chapter XIV.9
alcoholism : Chapter XX.3
aldosterone : Chapter V.4
alkaline phosphatase : Chapter IX.5
alkalosis : Chapter VIII.1
alkylating agents : Chapter XII.1
ALL : Chapter XII.2
allergic bronchopulmonary aspergillosis : Chapter VIII.3
allergic conjunctivitis : Chapter V.1
allergic dermatitis : Chapter XXI.6
allergic enteropathy : Chapter IX.10
allergic reaction : Chapter V.2
allergic rhinitis : Chapter V.1
allergic rhinitis : Chapter XXI.1
allergic shiner : Chapter V.1
allergy : Chapter V.1
allergy : Chapter V.2
allergy immunotherapy : Chapter V.1
allergy prevention : Chapter V.1
allogeneic transplant : Chapter V.6
alopecia : Chapter XVI.1
alpha fetoprotein : Chapter IV.1
alpha fetoprotein : Chapter XVIII.10
alpha globin : Chapter XI.2
alpha hemolytic strep : Chapter VI.2
alpha thal trait : Chapter XI.2
alpha thalassemia : Chapter XI.2
alpha-1-antitrypsin deficiency : Chapter IX.4
alpha-1-antitrypsin deficiency : Chapter IX.5
Alport's disease : Chapter XIII.1
ALTE : Chapter VIII.12
ALTE : Chapter IX.6
alternate cover test : Chapter XVII.3
amanita : Chapter XIV.9
ambiguous genitalia : Chapter XIII.11
amblyopia : Chapter XVII.2
amblyopia : Chapter XVII.3
ameba : Chapter VI.31
amebiasis : Chapter VI.31
amebiasis : Chapter IX.3
amebic abscess : Chapter X.11
amebic dysentery : Chapter IX.3
amebic liver abscess : Chapter IX.3
amelogenesis imperfecta : Chapter I.12
amenorrhea : Chapter XX.5
amenorrhea : Chapter XX.7
American trypanosomiasis : Chapter VI.31
Americans with Disabilities Act : Chapter I.8
amikacin : Chapter VI.5
aminocaproic acid : Chapter XI.6
aminoglycosides : Chapter VI.5
aminoglycosides : Chapter XVIII.6
aminophylline : Chapter VIII.2
amitriptyline : Chapter XIV.9
amniocentesis : Chapter IV.1
amniotic band syndrome : Chapter IV.2
amoxicillin : Chapter VI.5
amoxicillin : Chapter VI.10
amoxicillin/ampicillin rash : Chapter VI.22
amphetamine : Chapter XX.3
amphetamines : Chapter XIV.9
ampicillin : Chapter VI.5
ampicillin prophylaxis : Chapter III.10
ANA : Chapter XVI.1
anabolic steroids : Chapter XX.2
anaerobes : Chapter VI.2
anaerobes : Chapter X.11
anal fissure : Chapter IX.10
analgesia : Chapter XII.4
analgesics : Chapter XIV.4
analgesics : Chapter XIV.9
analysis of variance : Chapter XXII.1
anaphase lag : Chapter IV.7
anaphylactic shock : Chapter V.2
anaphylactoid purpura : Chapter IX.10
anaphylactoid reaction : Chapter V.2
anaphylaxis : Chapter V.2
anaphylaxis : Chapter V.3
anaphylaxis : Chapter XXI.5
ANCA : Chapter IX.11
Ancylostoma duodenale : Chapter VI.31
androgens : Chapter XXI.2
androstenedione : Chapter XV.4
anemia : Chapter III.5
anemia : Chapter XI.1
anemia : Chapter XI.3
anemia : Chapter XI.4
anemia : Chapter XII.4
anemia : Chapter XIII.5
anemia : Chapter XVI.1
anencephaly : Chapter IV.2
anencephaly : Chapter XVIII.10
anergy : Chapter V.5
anergy : Chapter VI.20
aneuploidy : Chapter IV.1
aneuploidy : Chapter IV.7
anger : Chapter XX.4
angioedema : Chapter V.2
angioedema : Chapter V.3
angiofibroma : Chapter XVIII.12
angiokeratoma circumscriptum : Chapter X.12
angioma : Chapter XVIII.19
angiomas : Chapter XVIII.1
angulation : Chapter XIX.1
anicteric leptospirosis : Chapter VI.28
animal bites : Chapter VI.13
animal bites : Chapter X.1
anion gap : Chapter II.4
anion gap : Chapter XIV.9
ankle posterior splint : Chapter XIX.2
ankle reflex : Chapter XVIII.1
ankle sprain : Chapter XIX.7
ankylosing spondylitis : Chapter XVI.2
anopheles mosquito : Chapter VI.30
ano-rectal manometry : Chapter IX.9
anorexia : Chapter XII.4
anorexia nervosa : Chapter XX.5
antacids : Chapter IX.6
anterior cruciate ligament injury : Chapter XIX.7
anthropometrics : Chapter II.1
anti-A : Chapter XI.7
antiangiogenesis agents : Chapter XII.1
anti-B : Chapter XI.7
anti-beta-lactamase : Chapter VI.2
antibiotic prophylaxis : Chapter VI.5
antibiotics : Chapter III.10
antibiotics : Chapter VI.5
anticholinergics : Chapter XIV.9
anticipatory guidance : Chapter I.6
anticoagulant : Chapter XI.6
anticoagulant : Chapter XVI.1
anticonvulsants : Chapter IV.2
anticonvulsants : Chapter XVIII.3
anticonvulsants : Chapter XVIII.4
antidepressants : Chapter I.10
antidepressants : Chapter XIV.9
antidiuretic hormone : Chapter XV.5
antidotes : Chapter XIV.9
anti-ds DNA : Chapter XVI.1
antiemetics : Chapter XII.1
antiemetics : Chapter XII.4
anti-endotoxin : Chapter XIV.2
anti-epileptic drugs (AED) : Chapter XVIII.4
anti-ganglioside antibody : Chapter XVIII.7
antigliadin antibodies : Chapter IX.12
antihistamine : Chapter V.1
antihistamines : Chapter V.2
antihistamines : Chapter XIV.9
antihistamines : Chapter XVII.4
antimalarials : Chapter XIV.9
anti-neutrophil cytoplasmic antibodies (ANCA) : Chapter IX.11
antinuclear antibody (ANA) : Chapter XVI.2
antiphospholipid antibody : Chapter XI.6
anti-retroviral therapy : Chapter VI.20
anti-Saccharomyces cerevisiae antibody (ASCA) : Chapter IX.11
anti-Sm : Chapter XVI.1
anti-staph penicillins : Chapter VI.5
anti-tissue transglutaminase : Chapter IX.12
anti-TNF-alpha : Chapter IX.11
aortic coarctation : Chapter VII.1
aortic coarctation : Chapter VII.2
aortic dissection : Chapter IV.5
aortic insufficiency : Chapter VII.2
aortic insufficiency : Chapter VII.4
aortic stenosis : Chapter VII.2
aortitis : Chapter VI.21
aortitis : Chapter VII.5
Apert's syndrome : Chapter X.10
aphasia : Chapter I.9
aphthoid lesions : Chapter IX.11
aplastic anemia : Chapter XI.1
aplastic anemia : Chapter XI.4
aplastic crisis : Chapter VI.1
aplastic crisis : Chapter XI.3
apnea : Chapter III.3
apnea : Chapter III.5
apnea : Chapter III.10
apnea : Chapter VI.10
apnea : Chapter VIII.10
apnea : Chapter VIII.12
apnea : Chapter IX.6
apophysitis : Chapter XIX.8
apparent life threatening event : Chapter VIII.12
appendiceal torsion : Chapter XIII.10
appendicitis : Chapter IX.2
appendicitis : Chapter X.3
appendicolith : Chapter X.3
appendix epididymis : Chapter XIII.10
appendix testis : Chapter XIII.10
Apt test : Chapter IX.10
aqueductal stenosis : Chapter XVIII.9
aqueous humor : Chapter XVII.2
arbovirus : Chapter VI.15
ARDS (adult respiratory distress syndrome) : Chapter VI.16
ARDS (adult respiratory distress syndrome) : Chapter XIV.3
arenavirus : Chapter VI.1
arginine vasopressin : Chapter XV.5
Argyll Robertson pupil : Chapter XVIII.1
Arnold-Chiari malformation : Chapter XVIII.10
Arnold-Chiari malformation : Chapter XVIII.16
arrhythmia : Chapter VII.6
arterial blood gas : Chapter VIII.1
arterial blood gas : Chapter XIV.3
arteriovenous malformation : Chapter XVIII.19
arthritis : Chapter VI.17
arthritis : Chapter VII.4
arthritis : Chapter XVI.1
arthritis : Chapter XVI.2
arthritis : Chapter XIX.5
arthrocentesis : Chapter XIX.5
arthropod bites/stings : Chapter XXI.5
arthropod vector : Chapter XXI.5
Ascaris lumbricoides : Chapter VI.31
ASD : Chapter VII.2
aseptic meningitis : Chapter VI.14
aseptic meningitis : Chapter VI.20
ash leaf spot : Chapter XVIII.1
ash leaf spot : Chapter XVIII.12
aspartate aminotransferase (AST) : Chapter IX.5
Asperger's disorder : Chapter I.9
aspergillosis : Chapter VIII.3
asphyxia : Chapter XIV.6
aspiration : Chapter VIII.5
aspiration : Chapter IX.6
aspiration pneumonia : Chapter VI.11
aspiration pneumonia : Chapter XVIII.2
aspirin : Chapter VI.17
asplenia : Chapter XI.3
asthma : Chapter VIII.2
asthma : Chapter XIV.3
asthma action plan : Chapter VIII.2
asthma management plan : Chapter VIII.2
astrocytoma : Chapter XVIII.12
astrocytoma : Chapter XVIII.18
astrovirus : Chapter IX.3
asystole : Chapter XIV.1
ataxia : Chapter VI.15
ataxia telangiectasia : Chapter V.5
ataxia telangiectasia : Chapter XVIII.11
ataxia telangiectasia : Chapter XVIII.12
atelectasis : Chapter VIII.6
atelectasis : Chapter XIV.3
atopic dermatitis : Chapter V.3
atopic dermatitis : Chapter XXI.1
atopic disease : Chapter VIII.2
atovaquone/proguanil : Chapter VI.30
atrial fibrillation : Chapter VII.6
atrial flutter : Chapter VII.6
atrial septal defect : Chapter VII.2
atropine : Chapter XIV.9
attention deficit disorder : Chapter I.8
attention deficit disorder : Chapter I.10
attention deficit/hyperactivity disorder : Chapter I.10
auditory brainstem response (ABR) : Chapter I.5
auditory nerve (CN VIII) : Chapter XVIII.1
autism : Chapter I.3
autism : Chapter I.8
autism : Chapter I.9
autistic disorder : Chapter I.9
autoimmune : Chapter XV.4
autoimmune thyroiditis : Chapter XV.2
autologous transplant : Chapter V.6
automated auditory brainstem response (AABR) : Chapter I.5
autosomal dominant : Chapter IV.4
autosomal dominant : Chapter IV.7
autosomal recessive : Chapter IV.4
autosomal recessive : Chapter IV.7
AV block : Chapter VII.6
AV fistula : Chapter XIII.4
AV graft : Chapter XIII.4
avascular necrosis, hip : Chapter XIX.6
AVM : Chapter XVIII.19
AVP : Chapter XV.5
axillary freckling : Chapter XVIII.1
axillary freckling : Chapter XVIII.11
axillary temperature : Chapter VI.3
azathioprine : Chapter IX.11
azathioprine : Chapter XVI.1
azithromycin : Chapter VI.5
azithromycin : Chapter VI.21
azithromycin : Chapter VI.29
azlocillin : Chapter VI.5
azoospermia : Chapter VIII.3
azotemia : Chapter XIII.1
azotemia : Chapter XIII.4
B12 deficiency : Chapter XI.1
Babinski's sign : Chapter XVIII.1
baby bottle (caries) syndrome : Chapter I.12
Bacillus : Chapter VI.2
Bacillus anthracis : Chapter VI.2
bacteremia : Chapter VI.2
bacteremia : Chapter VI.3
bacteremia : Chapter VI.16
bacterial conjunctivitis : Chapter XVII.4
bacterial endocarditis : Chapter VII.5
bacterial meningitis : Chapter VI.14
bacterial overgrowth : Chapter IX.12
bacterial vaginosis : Chapter VI.21
bactericidal : Chapter VI.4
bacteriocidal : Chapter VI.4
bacteriology : Chapter VI.5
bacteriostatic : Chapter VI.4
Bacteroides fragilis : Chapter VI.2
Bacteroides fragilis : Chapter VI.5
bag mask ventilation : Chapter XIV.1
balanced translocation : Chapter IV.7
barbiturate coma : Chapter XVIII.5
barbiturates : Chapter XIV.9
barbiturates : Chapter XX.3
barium enema : Chapter X.4
Barlow sign : Chapter XIX.6
barotrauma : Chapter III.5
barotrauma : Chapter XIV.3
Barr body : Chapter IV.7
Bartonella henselae : Chapter VI.29
base excess : Chapter VIII.1
basilar skull fracture : Chapter XVIII.13
Battle's sign : Chapter XVIII.13
Bayes theorem : Chapter XXII.2
BCG : Chapter VI.19
Becker muscular dystrophy : Chapter XVIII.14
Beckwith-Wiedemann syndrome : Chapter III.8
Beckwith-Wiedemann syndrome : Chapter XII.3
beclomethasone : Chapter VIII.2
behavior : Chapter I.7
bell clapper deformity : Chapter XIII.10
Bell's palsy : Chapter VI.27
benzodiazepines : Chapter XIV.9
benzodiazepines : Chapter XVIII.5
benzodiazepines : Chapter XX.3
benzoyl peroxide : Chapter XXI.2
Bernard-Soulier syndrome : Chapter XI.6
beta agonists : Chapter VIII.2
beta blockers : Chapter VII.1
beta globin : Chapter XI.2
beta globin chain : Chapter XI.3
beta hemolytic strep : Chapter VI.2
beta lactamase : Chapter VI.5
beta strep : Chapter VI.2
beta thalassemia major : Chapter XI.2
beta thalassemia minor : Chapter XI.2
beta-2 agonists : Chapter VIII.2
betacarotene : Chapter II.6
beta-lactamase : Chapter VI.2
bezoar : Chapter IX.7
Bezold abscess : Chapter VI.8
bicarbonate : Chapter VIII.1
bicarbonate : Chapter XV.4
biceps reflex : Chapter XVIII.1
bicuspid aortic valve : Chapter VII.2
biliary atresia : Chapter III.2
biliary atresia : Chapter IX.4
biliary colic : Chapter IX.2
bilirubin : Chapter III.2
binge eating : Chapter XX.5
biphasic anaphylaxis : Chapter V.2
biphasic reaction : Chapter VIII.2
bipolar depression : Chapter XX.4
birth asphyxia : Chapter III.8
birth control pills : Chapter XX.7
birth depression : Chapter III.10
bisexuality : Chapter XX.6
bites : Chapter XIV.9
BK virus : Chapter VI.1
Black Widow spider : Chapter XXI.5
blackhead : Chapter XXI.2
black-legged tick : Chapter VI.27
blackwater fever : Chapter VI.30
Blalock-Taussig shunt : Chapter VII.3
bleeding time : Chapter XI.6
blood brain barrier : Chapter VI.5
blood culture : Chapter III.10
blood gas : Chapter VIII.1
blood gas : Chapter XIV.3
blood gas, arterial : Chapter VIII.1
blood gas, capillary : Chapter VIII.1
blood gas, venous : Chapter VIII.1
blood transfusion : Chapter XIV.2
blood type : Chapter XI.7
Bloom syndrome : Chapter XVIII.11
blue dot sign : Chapter XIII.10
blueberry muffin rash : Chapter III.11
BMI : Chapter I.2
body image : Chapter XX.5
body mass index (BMI) : Chapter I.2
body mass index (BMI) : Chapter II.1
body surface area : Chapter XXI.4
bolus : Chapter II.4
bone age : Chapter XV.3
bone age : Chapter XX.1
bone marrow : Chapter XII.2
bone marrow failure : Chapter XI.4
bone marrow transplant : Chapter V.6
bone marrow transplantation : Chapter IV.6
bone marrow transplantation : Chapter XI.3
bone marrow transplantation : Chapter XII.1
bone scan : Chapter XIX.4
Bordetella pertussis : Chapter VI.10
Borrelia burgdorferi : Chapter VI.27
Boston exanthem : Chapter VI.22
botulinum immune globulin : Chapter XVIII.6
botulism : Chapter XIV.3
botulism : Chapter XVIII.6
bowel infarction : Chapter IX.2
bowel infarction : Chapter X.5
bowel ischemia : Chapter III.12
bowel obstruction : Chapter IX.2
bowel obstruction : Chapter X.4
bowel obstruction : Chapter X.5
bowing fracture : Chapter XIX.1
box jellyfish : Chapter XXI.5
BPD : Chapter VIII.4
brachioradialis reflex : Chapter XVIII.1
bradycardia : Chapter VII.6
bradycardia : Chapter XIV.1
brain abscess : Chapter X.11
brain injury : Chapter XVIII.13
brain malformation : Chapter XVIII.16
brain tumor : Chapter XVIII.18
brainstem auditory evoked response (BAER) : Chapter I.5
brainstem auditory evoked response : Chapter XVIII.8
breast feeding : Chapter II.1
breast feeding : Chapter II.3
breast feeding : Chapter III.1
breast milk : Chapter II.2
breastfeeding : Chapter II.2
breastfeeding : Chapter III.11
breastfeeding : Chapter VI.20
bronchial foreign body : Chapter VIII.6
bronchial inflammation : Chapter VIII.2
bronchial stenosis : Chapter VIII.6
bronchiectasis : Chapter VIII.3
bronchiectasis : Chapter VIII.5
bronchiectasis : Chapter VIII.6
bronchiolitis : Chapter VI.11
bronchiolitis : Chapter XIV.3
bronchitis : Chapter VI.11
bronchoalveolar lavage : Chapter VIII.7
bronchodilators : Chapter VIII.4
bronchogenic cyst : Chapter VIII.9
bronchography : Chapter VIII.5
bronchopulmonary dysplasia : Chapter III.6
bronchopulmonary dysplasia : Chapter VIII.1
bronchopulmonary dysplasia : Chapter VIII.4
bronchopulmonary dysplasia : Chapter XIV.3
bronchoscopy : Chapter VIII.6
bronchoscopy : Chapter VIII.10
bronchospasm : Chapter V.2
bronchospasm : Chapter VIII.2
bronchospasm : Chapter VIII.3
bronchospasm : Chapter VIII.4
bronchospastic phase : Chapter VIII.2
Bronstein : Chapter XIII.8
bronzing : Chapter XV.4
Broselow tape : Chapter XIV.1
brown recluse spider : Chapter XXI.5
brown violin spider : Chapter XXI.5
Brugia malayi : Chapter VI.31
Bruton's agammaglobulinemia : Chapter XXI.1
budesonide : Chapter VIII.2
buffy coat smear : Chapter VI.16
bulbar palsy : Chapter XVIII.6
bulimia : Chapter XX.5
bulla : Chapter XXI.6
bullous impetigo : Chapter VI.2
bunyavirus : Chapter VI.1
Burkholderia cepacia : Chapter VIII.3
Burkitt's lymphoma : Chapter VI.1
burns : Chapter XIV.12
burns : Chapter XXI.4
cachexia : Chapter XX.5
cafe au lait spots : Chapter XVIII.1
cafe au lait spots : Chapter XVIII.11
calcaneal apophysitis : Chapter XIX.8
calcidiol : Chapter XV.6
calcitonin : Chapter XV.6
calcitriol : Chapter XV.6
calcium : Chapter XV.6
calcivirus : Chapter VI.1
calcivirus : Chapter IX.3
calorie requirements : Chapter II.1
calories : Chapter II.3
Calymmatobacterium granulomatis : Chapter VI.21
camphor : Chapter XIV.9
Campylobacter : Chapter IX.3
Campylobacter enteritis : Chapter XVIII.7
cancer : Chapter XII.3
candida : Chapter VI.32
Candida albicans : Chapter VI.32
candida dermatitis : Chapter XXI.6
candida vaginitis : Chapter VI.32
candida vulvovaginitis : Chapter VI.21
candidiasis : Chapter VI.20
canine : Chapter I.12
cannabis : Chapter XX.3
capillary blood gas : Chapter VIII.1
capillary blood gas : Chapter XIV.3
capillary lymphangioma : Chapter X.12
capitation : Chapter I.11
CAP-RAST : Chapter V.3
caput succedaneum : Chapter III.1
car seats : Chapter I.6
carbamates : Chapter XIV.9
carbamazepine : Chapter XVIII.3
carbamazepine : Chapter XVIII.4
carbapenem : Chapter VI.5
carbapenem : Chapter VI.16
carbenicillin : Chapter VI.5
carbohydrate : Chapter II.1
carbohydrate : Chapter II.3
carbon monoxide : Chapter XIV.9
carbon monoxide poisoning : Chapter VIII.1
carbon monoxide poisoning : Chapter XXI.4
carboxyhemoglobin : Chapter VIII.1
cardiac arrest : Chapter XIV.1
cardiac output : Chapter XIV.2
cardiac rhabdomyoma : Chapter XVIII.12
cardiac tamponade : Chapter XIV.1
cardiogenic shock : Chapter VI.17
cardiogenic shock : Chapter XIV.8
cardiomegaly : Chapter VII.1
cardiomegaly : Chapter VII.2
cardiomyopathy : Chapter VII.1
cardiopulmonary arrest : Chapter XIV.1
cardiopulmonary resuscitation : Chapter XIV.1
cardiovascular collapse : Chapter V.2
cardioversion : Chapter VII.6
carditis : Chapter VII.4
carditis : Chapter VII.5
caries : Chapter I.12
case control study : Chapter XXII.3
case report : Chapter XXII.3
casein : Chapter II.2
casein : Chapter II.3
casein : Chapter V.3
cast : Chapter XIX.1
cast padding : Chapter XIX.2
cat scratch disease : Chapter VI.29
cat scratch disease : Chapter VI.34
catalase : Chapter VI.2
catarrhal stage : Chapter VI.10
catecholamine : Chapter XX.3
catecholamines : Chapter XIV.2
catecholamines : Chapter XV.4
categorical data : Chapter XXII.1
cathartics : Chapter XIV.9
cause and effect criteria : Chapter XXII.3
caustics : Chapter XIV.9
cavernous lymphangiomas : Chapter X.12
cavernous sinus thrombosis : Chapter VI.7
CBC : Chapter III.10
CBC : Chapter XI.1
CCAM (congenital cystic adenomatoid malformation) : Chapter VIII.9
CD4 lymphocytes : Chapter VI.20
cefaclor : Chapter VI.5
cefazolin : Chapter VI.5
cefotaxime : Chapter VI.5
cefotaxime : Chapter XVII.1
cefotetan : Chapter VI.5
cefoxitin : Chapter VI.5
ceftazidime : Chapter VI.5
ceftriaxone : Chapter VI.5
ceftriaxone : Chapter VI.21
ceftriaxone : Chapter XVII.1
cefuroxime : Chapter VI.5
celiac disease : Chapter IX.12
celiac sprue : Chapter IX.12
cellulitis : Chapter VI.2
cellulitis : Chapter VI.5
cellulitis : Chapter VI.13
cellulitis : Chapter VI.33
cellulitis : Chapter XVII.4
cementum : Chapter I.12
Centers for Medicare and Medicaid Services (CMS) : Chapter I.11
centipede : Chapter XXI.5
central hypoventilation syndrome : Chapter VIII.11
central venous catheter : Chapter VI.2
cephalexin : Chapter VI.5
cephalosporin : Chapter VI.2
cephalosporin : Chapter VI.16
cephalosporin generation : Chapter VI.5
cephalosporins : Chapter VI.5
cephalohematoma : Chapter III.1
cerebellar function : Chapter XVIII.1
cerebral edema : Chapter XIV.12
cerebral edema : Chapter XVIII.17
cerebral heterotopia : Chapter XVIII.16
cerebral palsy : Chapter I.8
cerebral palsy : Chapter VIII.4
cerebral palsy : Chapter XVIII.2
cerebral perfusion pressure : Chapter XVIII.13
cerebral perfusion pressure : Chapter XVIII.17
cerebral spinal fluid (CSF) : Chapter VI.14
cerebritis : Chapter XVI.1
cervical cancer : Chapter VI.21
cervical cerclage : Chapter III.4
cervical spine injury : Chapter XIV.8
cervicitis : Chapter VI.21
cestodes (tapeworms) : Chapter VI.31
Chagas disease : Chapter VI.31
chalazion : Chapter XVII.4
chamomile tea : Chapter IX.1
chancroid : Chapter VI.21
charcoal : Chapter XIV.9
Chediak-Higashi syndrome : Chapter V.5
Chediak-Higashi syndrome : Chapter XI.8
cheilitis : Chapter XXI.1
cheilosis : Chapter II.6
chelation therapy : Chapter XI.2
chemical conjunctivitis : Chapter XVII.1
chemical conjunctivitis : Chapter XVII.4
chemotherapy : Chapter XII.1
chest compressions : Chapter III.3
chest physical therapy : Chapter VIII.3
chest syndrome : Chapter XI.3
chest tube : Chapter XIV.7
chest x-ray : Chapter III.10
Chiari malformation : Chapter XVIII.9
Chiari malformation : Chapter XVIII.16
chickenpox : Chapter VI.1
chickenpox : Chapter VI.22
chickenpox : Chapter XXI.6
chickenpox vaccine : Chapter I.4
child abuse : Chapter VIII.12
child abuse : Chapter XIV.8
child abuse : Chapter XIV.12
child abuse : Chapter XXI.4
child development : Chapter I.3
child neglect : Chapter II.5
child neglect : Chapter XIV.12
childhood disintegrative disorder : Chapter I.9
chin lift : Chapter XIV.1
Chinese restaurant syndrome : Chapter V.3
Chi-square : Chapter XXII.1
Chlamydia : Chapter VI.2
Chlamydia : Chapter VI.5
Chlamydia : Chapter VI.10
Chlamydia : Chapter VI.11
Chlamydia : Chapter XVII.1
Chlamydia : Chapter XX.7
Chlamydia trachomatis : Chapter VI.21
Chlamydia trachomatis : Chapter XVII.4
chlamydial conjunctivitis : Chapter XVII.4
chloramphenicol : Chapter VI.5
chloroquine : Chapter VI.30
choking episode : Chapter VIII.6
cholera : Chapter IX.3
cholestasis : Chapter IX.4
cholestasis : Chapter IX.5
cholesteatoma : Chapter VI.6
cholinergic synapses : Chapter XVIII.6
cholinergics : Chapter XIV.9
chondrolysis : Chapter XIX.6
chorda tympani : Chapter XVIII.1
chordee : Chapter XIII.12
chorea : Chapter VII.4
choreoathetoid CP : Chapter XVIII.2
chorioamnionitis : Chapter III.10
chorioamnionitis : Chapter VI.2
chorionic villus sampling : Chapter IV.1
chorioretinitis : Chapter III.11
choroid : Chapter XVII.2
Christmas disease : Chapter XI.6
chromosomal breakage syndromes : Chapter IV.7
chronic active hepatitis : Chapter IX.11
chronic granulomatous disease (CGD) : Chapter V.5
chronic granulomatous disease (CGD) : Chapter XI.8
chronic hepatitis : Chapter IX.5
chronic lung disease : Chapter VIII.4
chronic mucocutaneous candidiasis : Chapter V.5
chronic obstructive pulmonary disease : Chapter VIII.1
chronic osteomyelitis : Chapter XIX.4
Chvostek sign : Chapter XV.6
ciclopirox : Chapter VI.32
cigarette smoking : Chapter XX.3
ciliary body : Chapter XVII.2
cimetidine : Chapter V.2
ciprofloxacin : Chapter VI.5
circadian rhythm dyssomnia : Chapter VIII.11
circumcision : Chapter III.1
circumcision : Chapter XIII.8
cirrhosis : Chapter VIII.3
clarithromycin : Chapter VI.5
classic hemophilia : Chapter XI.6
clavulanic acid : Chapter VI.2
clavulanic acid : Chapter VI.5
CLD : Chapter VIII.4
cleft lip : Chapter X.10
cleft palate : Chapter X.10
clindamycin : Chapter VI.5
clindamycin : Chapter VI.18
clindamycin : Chapter XXI.2
clinical trial : Chapter XXII.3
clonidine : Chapter XIV.9
Clonorchis : Chapter VI.31
closed fracture : Chapter XIX.1
closed reduction : Chapter XIX.1
Clostridium : Chapter VI.2
Clostridium botulinum : Chapter VI.2
Clostridium botulinum : Chapter XVIII.6
Clostridium difficile : Chapter VI.2
Clostridium difficile : Chapter VI.5
Clostridium perfringens : Chapter VI.2
Clostridium tetani : Chapter VI.2
clotrimazole : Chapter VI.32
clotrimazole : Chapter XXI.6
cloxacillin : Chapter VI.5
clubbing : Chapter VIII.3
clubbing : Chapter VIII.5
CMV : Chapter III.10
CMV : Chapter III.11
CMV : Chapter VI.1
CMV : Chapter VI.15
CMV : Chapter VI.34
CMV : Chapter XI.7
CNS hemorrhage : Chapter VI.10
coagulase : Chapter VI.2
coarctation of the aorta : Chapter VII.2
cobalt blue light : Chapter XVII.5
Cobb angle : Chapter XIX.3
cocaine : Chapter XIV.9
cocaine : Chapter XX.3
cockroach antigen : Chapter VIII.2
cohort study : Chapter XXII.3
coin : Chapter IX.7
colic : Chapter II.3
colic : Chapter IX.1
colic : Chapter IX.2
colitis : Chapter IX.3
colitis : Chapter IX.10
collagen : Chapter IV.5
collateral ligament injury : Chapter XIX.7
colloid : Chapter XIV.2
coloboma : Chapter XVII.2
colonic polyps : Chapter IX.10
combined oral contraceptives : Chapter XX.7
comedones : Chapter XXI.2
comminuted fracture : Chapter XIX.1
common variable immunodeficiency (CVID) : Chapter V.5
communicating hydrocele : Chapter X.2
communicating hydrocephalus : Chapter XVIII.9
communicating pneumothorax : Chapter XIV.7
compartment syndrome : Chapter XIX.2
compartment syndrome : Chapter XXI.4
complement deficiency : Chapter V.5
complete fracture : Chapter XIX.1
compound fracture : Chapter XIX.1
compound nevi : Chapter XXI.3
concussion : Chapter XVIII.13
conditioned play audiometry (CPA) : Chapter I.5
condoms : Chapter VI.21
condoms : Chapter XX.7
conduct disorder : Chapter I.10
conduct disorder : Chapter XX.4
conductive hearing loss : Chapter I.5
conductive hearing loss : Chapter VI.6
condyloma acuminata : Chapter XXI.6
condyloma acuminata : Chapter VI.1
condyloma acuminata : Chapter VI.21
condyloma lata : Chapter VI.21
confetti skin lesions : Chapter XVIII.12
confidence interval : Chapter XXII.1
confidence interval : Chapter XXII.2
confidentiality : Chapter XX.7
confounding variable : Chapter XXII.3
congenital adrenal hyperplasia : Chapter III.1
congenital adrenal hyperplasia : Chapter XIII.11
congenital adrenal hyperplasia : Chapter XV.4
congenital anomalies : Chapter IV.2
congenital CMV : Chapter III.11
congenital dislocated hip : Chapter XIX.6
congenital dyserythropoietic anemia (CDEA) : Chapter XI.1
congenital encephalitis : Chapter VI.15
congenital heart block : Chapter VII.6
congenital heart disease : Chapter III.6
congenital heart disease : Chapter III.7
congenital heart disease : Chapter III.8
congenital herpes : Chapter III.11
congenital hip dislocation : Chapter XIX.6
congenital HIV : Chapter III.11
congenital hypothyroidism : Chapter XV.2
congenital infection : Chapter III.9
congenital infection : Chapter III.11
congenital infection : Chapter VI.1
congenital intestinal aganglionosis : Chapter IX.9
congenital megacolon : Chapter IX.9
congenital muscular dystrophy : Chapter XVIII.14
congenital rubella : Chapter III.11
congenital short stature : Chapter I.2
congenital syphilis : Chapter III.11
congenital toxoplasmosis : Chapter III.11
congestive heart failure : Chapter VII.1
congestive heart failure : Chapter VII.2
congestive heart failure : Chapter VII.4
congestive heart failure : Chapter VII.5
congestive heart failure : Chapter VII.6
conjugated bilirubin : Chapter III.2
conjunctiva : Chapter XVII.2
conjunctival edema : Chapter V.2
conjunctivitis : Chapter V.1
conjunctivitis : Chapter VI.1
conjunctivitis : Chapter XVII.1
conjunctivitis : Chapter XVII.4
connective tissue disorders : Chapter IV.5
constipation : Chapter IX.2
constipation : Chapter IX.8
constipation : Chapter XII.4
constitutional growth delay : Chapter I.2
constitutional growth delay : Chapter II.5
constitutional growth delay : Chapter XV.3
constitutional growth delay : Chapter XX.1
contact dermatitis : Chapter XXI.6
continuous data : Chapter XXII.1
continuous positive airway pressure : Chapter III.5
continuous positive airway pressure : Chapter III.6
contraception : Chapter XX.7
contraceptive patch : Chapter XX.7
contraceptive sponge : Chapter XX.7
contractility : Chapter XIV.2
contrast enema : Chapter X.4
convalescent stage : Chapter VI.10
convulsion : Chapter XVIII.3
convulsion : Chapter XVIII.5
Cooley's anemia : Chapter XI.2
Coombs test : Chapter XI.7
Coombs test : Chapter III.2
co-oximetry : Chapter VIII.1
COPD : Chapter VIII.1
copolymer I : Chapter XVIII.8
cor pulmonale : Chapter VIII.3
cor pulmonale : Chapter VIII.4
cord hydrocele : Chapter X.2
core temperature : Chapter VI.3
corn syrup : Chapter II.3
cornea : Chapter XVII.2
corneal abrasion : Chapter XVII.5
corneal light reflex : Chapter XVII.2
corneal reflection test : Chapter XVII.3
corneal reflex : Chapter XVIII.1
corneal ulcer : Chapter XVII.5
coronary aneurysms : Chapter VI.17
coronavirus : Chapter VI.1
coronavirus : Chapter VI.9
corporal punishment : Chapter I.6
corporal punishment : Chapter XX.4
corticospinal tract : Chapter XVIII.1
corticosteroids : Chapter V.1
corticosteroids : Chapter V.2
corticosteroids : Chapter V.4
corticosteroids : Chapter VIII.2
corticosteroids : Chapter VIII.4
corticosteroids : Chapter IX.11
corticosteroids : Chapter XIV.3
corticosteroids : Chapter XV.3
corticosteroids : Chapter XV.4
corticosteroids : Chapter XVI.1
corticosteroids : Chapter XVII.4
corticosteroids : Chapter XVIII.8
corticosteroids : Chapter XXI.1
corticosteroids : Chapter XXI.6
corticosteroids. : Chapter XVIII.14
cortisol : Chapter V.4
cortisol : Chapter XV.4
cortisol deficiency : Chapter III.8
Corynebacteria : Chapter VI.2
Corynebacteria diphtheria : Chapter VI.2
co-sleeping : Chapter VIII.12
coumadin : Chapter IV.2
coumadin : Chapter XI.6
cover test : Chapter XVII.2
cover-uncover test : Chapter XVII.3
cowpox : Chapter VI.1
cow's milk allergy : Chapter II.3
cow's milk allergy : Chapter XI.1
cow's milk allergy : Chapter XI.4
cow's milk anemia : Chapter XI.1
cows' milk protein sensitivity : Chapter IX.10
coxsackie virus : Chapter VI.1
coxsackie virus : Chapter VI.9
coxsackie virus : Chapter VI.22
CPAP (continuous positive airway pressure) : Chapter III.5
CPAP (continuous positive airway pressure) : Chapter VII.1
CPAP (continuous positive airway pressure) : Chapter XIV.3
CPT codes : Chapter I.11
cradle cap : Chapter XXI.1
cramps : Chapter IX.2
cranial nerves : Chapter XVIII.1
craniofacial malformation : Chapter X.10
craniopharyngioma : Chapter XVIII.18
craniosynostosis : Chapter X.10
craniosynostosis : Chapter XVIII.1
craniotabes : Chapter III.1
C-reactive protein : Chapter XIX.4
cremasteric reflex : Chapter XIII.10
crescent sign : Chapter X.4
Cri du Chat syndrome : Chapter VIII.5
Crohn's disease : Chapter IX.11
cromolyn : Chapter V.1
cromolyn : Chapter VIII.2
cromolyn : Chapter VIII.4
crossed eyes : Chapter XVII.3
crossmatch : Chapter XI.7
croup : Chapter VI.1
croup : Chapter VI.12
croup : Chapter XIV.3
Crouzon's disease : Chapter X.10
CRP : Chapter XIX.4
cruciate ligament injury : Chapter XIX.7
crusts : Chapter XXI.6
crying : Chapter IX.1
cryoglobulinemic vasculitis : Chapter XVI.3
crypt abscesses : Chapter IX.11
cryptorchidism : Chapter XIII.12
cryptosporidiosis : Chapter IX.3
cryptosporidium : Chapter VI.31
cryptosporidium : Chapter IX.3
crystalloid : Chapter XIV.2
crystalloid : Chapter XIV.8
CSF : Chapter III.10
CT scan : Chapter XIX.4
currant jelly stool : Chapter X.4
curved blade : Chapter XIV.4
Cushing's disease : Chapter XV.4
Cushing's syndrome : Chapter V.4
Cushing's syndrome : Chapter XV.4
Cushing's triad : Chapter XVIII.13
cutaneous leukocytoclastic vasculitis : Chapter XVI.3
CXR : Chapter III.10
cyanide : Chapter XIV.9
cyanocobalamin : Chapter II.6
cyanosis : Chapter III.7
cyanosis : Chapter III.10
cyanosis : Chapter VII.3
cyanosis : Chapter VIII.1
cyanosis : Chapter VIII.4
cyanotic congenital heart disease : Chapter III.6
cyanotic congenital heart disease : Chapter VII.3
cyclophosphamide : Chapter XVI.1
cycloplegic : Chapter XVII.5
cycloserine : Chapter VI.19
cyclosporin(e) : Chapter IX.11
cyclosporin(e) : Chapter XVI.1
cyclosporin(e) : Chapter XXI.1
cyst : Chapter XXI.6
cystic adenomatoid malformation : Chapter VIII.9
cysticercosis : Chapter VI.31
cystic fibrosis : Chapter IV.1
cystic fibrosis : Chapter VIII.3
cystic fibrosis : Chapter VIII.5
cystic fibrosis : Chapter IX.5
cystic hygroma : Chapter X.12
cystic kidneys : Chapter XIII.3
cystic lymphangiomas : Chapter X.12
cystitis : Chapter XIII.6
cytochrome p450 : Chapter IX.5
cytogenetics : Chapter XII.2
cytomegalovirus (CMV) : Chapter III.10
cytomegalovirus (CMV) : Chapter III.11
cytomegalovirus (CMV) : Chapter VI.1
cytomegalovirus (CMV) : Chapter VI.15
cytomegalovirus (CMV) : Chapter VI.34
cytomegalovirus (CMV) : Chapter XI.7
dactylitis : Chapter XI.3
Dandy Walker malformation : Chapter XVIII.9
DDAVP : Chapter XI.6
DDAVP : Chapter XIII.9
DDAVP : Chapter XV.5
D-dimer : Chapter XI.6
DDST : Chapter I.3
decongestants : Chapter XIV.9
decontamination : Chapter XIV.9
decubitus CXR views : Chapter VIII.6
deer tick : Chapter VI.27
DEET : Chapter VI.27
deferoxamine : Chapter XI.2
deferoxamine : Chapter XIV.11
defibrillation : Chapter XIV.1
degenerative hip disease : Chapter XIX.6
dehydration : Chapter II.4
dehydration : Chapter IX.3
dehydration : Chapter X.3
dehydration : Chapter X.8
dehydrocholesterol : Chapter II.6
delayed hypersensitivity : Chapter V.5
delayed meconium passage : Chapter IX.9
delayed meconium : Chapter IX.8
delayed primary closure : Chapter X.1
deletion : Chapter IV.7
delirium : Chapter XX.3
delivery room resuscitation : Chapter III.3
delta agent : Chapter IX.5
demyelination : Chapter XVIII.7
demyelination : Chapter XVIII.8
dengue fever : Chapter VI.1
dense body deficiency : Chapter XI.6
dental care : Chapter I.6
dental caries : Chapter I.6
dental decay : Chapter I.12
dental home : Chapter I.6
dentin : Chapter I.12
dentinogenesis imperfecta : Chapter I.12
Denver developmental screening test : Chapter I.3
Denys-Drash syndrome : Chapter XII.3
deoxycorticosterone acetate (DOCA) : Chapter XV.4
depo(t) medroxyprogesterone (Provera) : Chapter XX.7
depressed skull fracture : Chapter XVIII.13
depression : Chapter XX.4
Dermacentor andersoni : Chapter VI.26
Dermacentor variabilis : Chapter VI.26
dermatitis : Chapter XXI.1
dermatomyositis : Chapter XVIII.15
dermatophyte : Chapter VI.32
dermis : Chapter XXI.6
descriptive statistics : Chapter XXII.1
desipramine : Chapter I.10
desmopressin : Chapter XI.6
desmopressin : Chapter XV.5
detoxification : Chapter XIV.9
development : Chapter I.7
developmental brain anomaly : Chapter XVIII.16
developmental delay : Chapter I.3
developmental dysplasia of the hip : Chapter XIX.6
developmental language disorder : Chapter I.9
developmental screening : Chapter I.3
dexamethasone : Chapter V.4
dexamethasone : Chapter VIII.2
dexamethasone : Chapter VIII.4
dextroamphetamine : Chapter I.10
DFA : Chapter VI.10
diabetes : Chapter IV.2
diabetes : Chapter XIII.9
diabetes insipidus : Chapter XV.5
diabetes mellitus : Chapter VIII.3
diabetes mellitus : Chapter XV.1
diabetic ketoacidosis : Chapter VIII.1
diabetic ketoacidosis : Chapter IX.2
diabetic ketoacidosis : Chapter XV.1
dialysis : Chapter XIII.4
dialysis : Chapter XIII.5
Diamond-Blackfan anemia : Chapter XI.1
Diamond-Blackfan anemia : Chapter XI.4
diaper dermatitis : Chapter XXI.6
diaphragm : Chapter XX.7
diaphragmatic hernia : Chapter III.6
diaphragmatic hernia : Chapter III.7
diaphragmatic hernia : Chapter X.7
diaphysis : Chapter XIX.1
diaphysis : Chapter XIX.4
diarrhea : Chapter II.4
diarrhea : Chapter IX.3
diarrhea : Chapter XIII.5
diazepam : Chapter XVIII.3
diazepam : Chapter XVIII.5
DIC : Chapter VI.16
dicloxacillin : Chapter VI.5
dietary protein enterocolitis : Chapter V.3
diethylcarbamazine : Chapter VI.31
DiGeorge anomaly : Chapter V.5
DiGeorge syndrome : Chapter XV.6
digital clubbing : Chapter VIII.3
digoxin : Chapter VII.1
digoxin : Chapter XIV.9
diphenhydramine : Chapter V.2
diphenhydramine : Chapter XIV.9
Diphtheria : Chapter VI.2
diphtheria toxoid : Chapter I.4
diphtheria toxoid : Chapter VI.2
Diphtheroids : Chapter VI.2
Diphyllobothrium latum : Chapter VI.31
direct antibody test : Chapter III.2
direct antibody test (DAT) : Chapter XI.7
direct bilirubin : Chapter III.2
direct fluorescent antibody : Chapter VI.10
disability : Chapter I.8
discipline : Chapter I.6
discipline : Chapter I.7
discoid rash : Chapter XVI.1
DISIDA scan : Chapter IX.4
disk battery : Chapter IX.7
dislocation : Chapter XIX.7
disseminated intravascular coagulation : Chapter VI.16
disseminated intravascular coagulation (DIC) : Chapter XI.6
distortion product otoacoustic emissions (DPOAE) : Chapter I.5
diuretics : Chapter VIII.4
diverticulitis : Chapter IX.13
DKA : Chapter XV.1
D-lysergic acid diethylamide : Chapter XX.3
DNA chip technology : Chapter IV.6
DNA virus : Chapter VI.1
dobutamine : Chapter VI.16
dobutamine : Chapter VII.1
dobutamine : Chapter XIV.2
dog tick : Chapter VI.26
doll's eyes : Chapter XVIII.1
dominant inheritance : Chapter IV.4
dopamine : Chapter I.10
dopamine : Chapter VI.16
dopamine : Chapter VII.1
dopamine : Chapter XIV.2
Doppler ultrasonography : Chapter XIII.10
dorsal columns : Chapter XVIII.1
double aortic arch : Chapter VII.7
double blinding : Chapter XXII.2
double blinding : Chapter XXII.3
double bubble sign : Chapter X.9
double stranded DNA virus : Chapter VI.1
Down Syndrome : Chapter I.2
Down syndrome : Chapter IV.3
Down syndrome : Chapter XI.5
downers : Chapter XX.3
doxycycline : Chapter VI.5
doxycycline : Chapter VI.21
doxycycline : Chapter VI.26
doxycycline : Chapter VI.30
doxycycline : Chapter XXI.2
DPT vaccine : Chapter I.4
Dracunculus medinensis (Guinea worm) : Chapter VI.31.
draw and tag : Chapter XI.7
drooling : Chapter IX.7
drowning : Chapter I.6
drowning : Chapter XIV.6
drug abuse : Chapter XX.3
drug addiction : Chapter XX.3
drug dependence : Chapter XX.3
dry drowning : Chapter XIV.6
DSM-IV : Chapter I.10
dT vaccine : Chapter I.4
DTaP vaccine : Chapter VI.10
DTP vaccine : Chapter VI.10
DUB : Chapter XX.7
Duchenne muscular dystrophy : Chapter XVIII.14
duck embryo vaccine (DEV) : Chapter VI.25
dumb rabies : Chapter VI.25
duodenal atresia : Chapter X.9
dust mite antigens : Chapter VIII.2
dysdiadochokinesia : Chapter XVIII.1
dysentery : Chapter VI.2
dysentery : Chapter IX.3
dysentery : Chapter XIII.5
dysfunctional uterine bleeding : Chapter XX.7
dysgenetic gonads : Chapter XIII.11
dyskeratosis congenita : Chapter XI.4
dyskinetic CP : Chapter XVIII.2
dysmenorrhea : Chapter XX.7
dysphagia : Chapter VII.7
dysphagia : Chapter IX.7
dyspnea : Chapter III.7
dysrhythmia : Chapter VII.6
dyssomnia : Chapter VIII.11
dystrophin : Chapter XVIII.14
dysuria : Chapter XIII.10
E. coli : Chapter III.10
E. coli : Chapter IX.3
E. coli O157 : Chapter VI.2
E. coli O157 : Chapter XIII.5
Eagle effect : Chapter VI.18
Eagle-Barrett Syndrome : Chapter XIII.7
early childhood caries : Chapter I.12
eastern equine encephalitis : Chapter VI.1
eastern equine encephalitis : Chapter VI.15
eating disorders : Chapter XX.5
EBM : Chapter XXII.2
Ebola virus : Chapter VI.1
Ebstein anomaly : Chapter VII.3
EBV : Chapter VI.1
EBV : Chapter VI.23
echovirus : Chapter VI.1
echovirus : Chapter VI.22
ECMO : Chapter III.6
ECMO : Chapter III.7
ECMO : Chapter X.7
ecstasy : Chapter XX.3
ecthyma gangrenosum : Chapter VI.16
eczema : Chapter XXI.1
edema : Chapter XIII.1
Edwards syndrome : Chapter IV.3
EEG : Chapter III.9
EEG : Chapter XVIII.3
EEG : Chapter XVIII.4
EEG : Chapter XVIII.5
EEG : Chapter XVIII.12
EES : Chapter VI.5
egg allergy : Chapter V.3
Ehlers-Danlos syndrome : Chapter IV.5
Ehlers-Danlos syndrome : Chapter VIII.5
Ehrlichiosis : Chapter VI.26
Eisenmenger's syndrome : Chapter VII.3
elastin : Chapter IV.5
elbow tendonitis : Chapter XIX.8
electroencephalogram (EEG) : Chapter XVIII.4
electrolytes : Chapter II.4
electromechanical dissociation : Chapter XIV.1
electromyography : Chapter XVIII.6
electromyography : Chapter XVIII.7
electromyography : Chapter XVIII.14
electromyography : Chapter XVIII.15
elephantiasis : Chapter VI.31
ELISA : Chapter VI.20
emboli : Chapter VII.5
EMD : Chapter XIV.1
emergency contraception : Chapter XX.7
emergency medical services (EMS) : Chapter XIV.1
Emery-Dreifuss muscular dystrophy : Chapter XVIII.14
EMG : Chapter XVIII.14
emphysema : Chapter VIII.1
empiric antibiotics : Chapter III.10
empiric antibiotics : Chapter VI.5
empyema : Chapter VI.11
EMS : Chapter XIV.1
enamel : Chapter I.12
enanthem : Chapter VI.22
encephalitis : Chapter VI.1
encephalitis : Chapter VI.15
encephalitis : Chapter VI.25
encephalitis : Chapter XVIII.5
encephalopathy : Chapter IV.4
encephalopathy : Chapter VI.10
encephalopathy : Chapter VI.29
encephalopathy : Chapter XVIII.17
encopresis : Chapter IX.8
end tidal CO2 : Chapter XIV.4
endocarditis : Chapter VI.2
endocarditis : Chapter VI.4
endocarditis : Chapter VII.5
endocarditis prophylaxis : Chapter VII.5
endometritis : Chapter VI.21
endoscopy : Chapter IX.7
endoscopy : Chapter IX.10
endotoxin : Chapter VI.2
endotoxin : Chapter VI.18
endotoxin shock : Chapter VI.16
endotracheal intubation : Chapter XIV.1
endotracheal intubation : Chapter XIV.4
endotracheal tube : Chapter XIV.1
endotracheal tube : Chapter XIV.4
enema : Chapter IX.8
Entamoeba histolytica : Chapter VI.31
Entamoeba histolytica : Chapter IX.3
enteric adenovirus : Chapter IX.3
enteritis : Chapter IX.3
Enterobacteriaceae : Chapter VI.2
Enterobius vermicularis : Chapter VI.31
enterococcus : Chapter VI.2
enterocolitis : Chapter IX.8
enterocolitis : Chapter IX.9
enteropathogenic E. coli : Chapter VI.2
enterotoxigenic E. coli : Chapter VI.2
enterotoxin : Chapter VI.18
enterotoxin : Chapter IX.3
enterovirus : Chapter VI.1
enuresis : Chapter VIII.11
enuresis : Chapter XIII.9
enuresis : Chapter XV.1
enveloped virus : Chapter VI.1
envenomation : Chapter XXI.5
enzyme deficiency : Chapter IV.4
eosinophilia : Chapter VI.31
eosinophilic gastroenteropathies : Chapter V.3
ependymoma : Chapter XVIII.18
epidemiology : Chapter XXII.3
epidermis : Chapter XXI.6
Epidermophyton : Chapter VI.32
epididymitis : Chapter VI.21
epididymitis : Chapter XIII.10
epidural abscess : Chapter VI.7
epidural hematoma : Chapter XVIII.13
epiglottitis : Chapter VI.12
epiglottitis : Chapter XIV.3
epilepsy : Chapter IV.2
epilepsy : Chapter XVIII.3
epilepsy : Chapter XVIII.4
epilepsy : Chapter XVIII.5
epilepsy : Chapter XVIII.11
epilepsy : Chapter XVIII.12
epinephrine : Chapter III.3
epinephrine : Chapter V.2
epinephrine : Chapter VI.12
epinephrine : Chapter VI.16
epinephrine : Chapter VIII.2
epinephrine : Chapter XIV.1
epinephrine : Chapter XIV.2
epinephrine : Chapter XIV.3
epiphysis : Chapter XIX.1
episcleritis : Chapter IX.11
epispadias : Chapter XIII.12
epistaxis : Chapter IX.10
epsilon aminocaproic acid : Chapter XI.6
Epstein Barr virus (EBV) : Chapter VI.1
Epstein Barr virus (EBV) : Chapter VI.9
Epstein Barr virus (EBV) : Chapter VI.15
Epstein Barr virus (EBV) : Chapter VI.22
Epstein Barr virus (EBV) : Chapter VI.23
Epstein Barr virus (EBV) : Chapter VI.34
equine encephalitis : Chapter VI.1
erosions : Chapter XXI.6
erysipelas : Chapter VI.13
erythema infectiosum : Chapter VI.1
erythema infectiosum : Chapter VI.22
erythema marginatum : Chapter VII.4
erythema multiforme : Chapter V.2
erythema multiforme : Chapter VI.17
erythema nodosum : Chapter IX.11
erythema toxicum : Chapter XXI.6
erythrocyte sedimentation rate : Chapter XIX.4
erythrocytic schizogony : Chapter VI.30
erythromycin : Chapter VI.5
erythromycin : Chapter VI.10
erythromycin : Chapter XVII.1
erythromycin : Chapter XXI.2
erythromycin estolate : Chapter VI.5
erythromycin ethylsuccinate : Chapter VI.5
erythromycin ophthalmic : Chapter III.1
erythromycin propyl-laurel sulfate : Chapter VI.5
erythropoietin : Chapter VIII.1
erythropoietin : Chapter XI.1
Escherichia coli : Chapter VI.2
esophageal atresia : Chapter X.9
esophageal foreign body : Chapter IX.7
esophageal varices : Chapter IX.10
esophagitis : Chapter IX.6
esophagitis : Chapter IX.10
esophagram : Chapter VII.7
esotropia : Chapter XVII.3
ESR : Chapter XIX.4
ethambutol : Chapter VI.19
ethanol : Chapter XIV.9
ethionamide : Chapter VI.19
ethmoid sinus : Chapter VI.7
ethylene glycol : Chapter XIV.9
euploidy : Chapter IV.7
eustachian tube : Chapter VI.6
evidence-based medicine : Chapter XXII.2
exanthem : Chapter VI.22
exanthem subitum : Chapter VI.22
exchange transfusion : Chapter III.2
exchange transfusion : Chapter III.8
excoriations : Chapter XXI.6
exocrine dysfunction : Chapter VIII.3
exotoxin : Chapter VI.2
exotoxin shock : Chapter VI.16
exotropia : Chapter XVII.3
experimental design : Chapter XXII.3
expiratory CXR view : Chapter VIII.6
external fixation : Chapter XIX.1
external rotation method of shoulder reduction : Chapter XIX.7
extracellular fluid (ECF) : Chapter II.4
extracorporeal membrane oxygenation : Chapter X.7
extrahepatic biliary atresia : Chapter IX.4
extramedullary hematopoiesis : Chapter XI.2
extraocular movements : Chapter XVIII.1
extravaginal torsion : Chapter XIII.10
eye patch : Chapter XVII.5
eye patching : Chapter XVII.3
eye prophylaxis : Chapter XVII.1
facial nerve (CN VII) : Chapter XVIII.1
Facioscapulohumeral dystrophy : Chapter XVIII.14
Fagan nomogram : Chapter XXII.2
failure to thrive : Chapter I.2
failure to thrive : Chapter II.1
failure to thrive : Chapter II.5
failure to thrive : Chapter VI.20
failure to thrive : Chapter VIII.3
failure to thrive : Chapter VIII.10
failure to thrive : Chapter IX.6
failure to thrive : Chapter IX.12
failure to thrive : Chapter XIV.12
famciclovir : Chapter VI.21
familial glomerulonephritis : Chapter XIII.1
familial short stature : Chapter I.2
familial short stature : Chapter XV.3
Fanconi anemia : Chapter XVIII.11
Fanconi's anemia : Chapter XI.4
fasciitis : Chapter VI.33
fasciola : Chapter VI.31
fat : Chapter II.1
fat : Chapter II.3
fat soluble vitamin deficiency : Chapter VIII.3
fatigue : Chapter XII.4
fatty acid oxidation : Chapter XVIII.17
febrile seizure : Chapter VI.3
febrile seizure : Chapter XVIII.3
febrile seizure, atypical : Chapter XVIII.3
febrile seizure, complex : Chapter XVIII.3
febrile seizure, recurrent : Chapter XVIII.3
febrile seizure, simple : Chapter XVIII.3
fecalith : Chapter X.3
fee for service (FFS) : Chapter I.11
female condoms : Chapter XX.7
ferritin : Chapter XI.1
fetal alcohol syndrome : Chapter III.4
fetal alcohol syndrome : Chapter IV.2
fetal distress : Chapter III.10
fetal hydrops : Chapter XI.2
fetal malformation : Chapter III.3
FEV1 : Chapter VIII.2
fever : Chapter VI.3
fiberglass : Chapter XIX.2
Fifth's disease : Chapter VI.1
Fifth's disease : Chapter VI.22
filovirus : Chapter VI.1
finger sweep : Chapter VIII.6
FiO2 : Chapter XIV.5
first degree burns : Chapter XXI.4
fish allergy : Chapter V.3
fissures : Chapter XXI.6
Fitz-Hugh-Curtis syndrome : Chapter VI.21
flaccidity : Chapter XVIII.6
flaccidity : Chapter XVIII.7
flavivirus : Chapter VI.1
flesh eating bacteria : Chapter VI.13
fluconazole : Chapter VI.32
fludrocortisone : Chapter XV.4
fluid loss : Chapter XXI.4
fluid requirements : Chapter II.1
fluids : Chapter II.4
flunisolide : Chapter VIII.2
fluorescein : Chapter XVII.5
fluoridation : Chapter II.1
fluoride : Chapter I.6
fluoride : Chapter I.12
fluorosis : Chapter I.12
fluticasone : Chapter VIII.2
focal segmental glomerulosclerosis : Chapter XIII.2
folate deficiency : Chapter XI.1
Foley catheter removal : Chapter IX.7
fomepizole : Chapter XIV.9
Fontan procedure : Chapter VII.3
food allergy : Chapter V.3
food borne botulism : Chapter XVIII.6
food borne infection : Chapter IX.3
food intolerance : Chapter V.3
food poisoning : Chapter VI.2
food poisoning : Chapter IX.3
foramen of Bochdalek : Chapter X.7
forceps delivery : Chapter III.3
Forchheimer's sign : Chapter VI.22
foregut cyst : Chapter VIII.9
foreign body : Chapter IX.7
foreign body : Chapter X.1
foreign body aspiration : Chapter VIII.6
foreign body aspiration : Chapter XIV.3
formoterol : Chapter VIII.2
formula : Chapter II.1
formula : Chapter II.3
fourth degree burn : Chapter XXI.4
fovea : Chapter XVII.2
fracture : Chapter XIV.12
fracture : Chapter XIX.1
Fragile X syndrome : Chapter IV.3
fresh frozen plasma : Chapter XIV.2
frontal osteomyelitis : Chapter VI.7
frontal sinus : Chapter VI.7
FTA-Abs : Chapter VI.21
FTT : Chapter II.5
full thickness burn : Chapter XXI.4
functional asplenia : Chapter XI.3
funduscopy : Chapter XVII.2
furious rabies : Chapter VI.25
furosemide : Chapter VIII.4
furosemide : Chapter XV.4
G6PD deficiency : Chapter III.2
G6PD deficiency : Chapter IV.1
G6PD deficiency : Chapter VI.5
G6PD deficiency : Chapter VI.26
G6PD deficiency : Chapter XI.1
GABA : Chapter XX.3
gag reflex : Chapter XVIII.1
galactosemia : Chapter II.3
galactosemia : Chapter III.1
galactosemia : Chapter III.2
galactosemia : Chapter III.8
galactosemia : Chapter IV.4
galactosemia : Chapter IX.5
Galeazzi sign : Chapter XIX.6
gamma amino butyric acid (GABA) : Chapter XX.3
gamma globulin : Chapter IX.5
gamma hemolytic strep : Chapter VI.2
gamma-glutamyl transpeptidase (GGT) : Chapter IX.5
gamma-hydroxybutyrate : Chapter XX.3
Gardnerella vaginalis : Chapter VI.21
gas gangrene : Chapter VI.33
gastric erosion : Chapter IX.10
gastric foreign body : Chapter IX.7
gastric lavage : Chapter XIV.9
gastric lavage : Chapter XIV.10
gastritis : Chapter IX.10
gastroenteritis : Chapter II.4
gastroenteritis : Chapter VI.1
gastroenteritis : Chapter VI.2
gastroenteritis : Chapter IX.2
gastroenteritis : Chapter IX.3
gastroesophageal reflux : Chapter VIII.4
gastroesophageal reflux : Chapter VIII.5
gastroesophageal reflux : Chapter IX.6
gastroesophageal reflux : Chapter XVIII.2
gastroschisis : Chapter X.6
GBS prophylaxis : Chapter III.10
gender identity : Chapter XX.6
gene therapy : Chapter IV.6
generalized seizure : Chapter XVIII.4
genetic counseling : Chapter XVIII.11
genetic counseling : Chapter XVIII.12
genetic screening : Chapter IV.1
genetic testing : Chapter IV.6
genital herpes : Chapter VI.1
genital herpes : Chapter VI.21
gentamicin : Chapter VI.5
gentian violet : Chapter VI.32
GER : Chapter VIII.4
GER : Chapter IX.6
German measles : Chapter VI.22
germinal matrix hemorrhage : Chapter III.5
GHB : Chapter XX.3
GI bleeding : Chapter IX.10
GI bleeding : Chapter IX.13
GI decontamination : Chapter XIV.9
giant platelet syndrome : Chapter XI.6
Giardia lamblia : Chapter VI.31
Giardia lamblia : Chapter IX.3
giardiasis : Chapter VI.31
giardiasis : Chapter IX.3
giardiasis : Chapter IX.12
gingivitis : Chapter VI.9
gingivostomatitis : Chapter VI.9
glanuloplasty : Chapter XIII.12
Glanzmann thrombasthenia : Chapter XI.6
glargine insulin : Chapter XV.1
Glasgow Coma Scale : Chapter XVIII.13
glaucoma : Chapter XVII.2
glaucoma : Chapter XVII.5
Glenn procedure : Chapter VII.3
glioma : Chapter XVIII.18
glomerulonephritis : Chapter VI.2
glomerulonephritis : Chapter XIII.1
glomerulonephritis : Chapter XIII.5
glossitis : Chapter II.6
glossitis : Chapter VI.9
glossopharyngeal nerve (CN IX) : Chapter XVIII.1
glucagon deficiency : Chapter III.8
glucocorticoids : Chapter V.4
glucocorticoids : Chapter VIII.2
glucocorticoids : Chapter XV.4
gluconeogenesis : Chapter III.8
glucose : Chapter III.8
glucose : Chapter XIV.9
glucose polymer : Chapter II.3
glue sniffing : Chapter XX.3
gluten enteropathy : Chapter IX.12
gluten sensitivity : Chapter IX.12
glycerin : Chapter IX.8
glycogen : Chapter III.8
glycosuria : Chapter XV.1
glycosylated hemoglobin : Chapter XV.1
gold standard : Chapter XXII.3
Gomco : Chapter XIII.8
gonadal dysgenesis : Chapter XIII.11
gonococcal conjunctivitis : Chapter XVII.4
gonorrhea : Chapter VI.2
gonorrhea : Chapter VI.21
gonorrhea : Chapter XVII.1
gonorrhea : Chapter XVII.4
gonorrhea : Chapter XIX.5
gonorrhea : Chapter XX.7
Goodpasture's disease : Chapter VIII.7
Goodpasture's disease : Chapter XIII.1
Gowers' maneuver : Chapter XVIII.14
Gowers' sign : Chapter XVIII.15
graft versus host disease : Chapter V.6
graft versus host disease : Chapter XII.1
gram negative bacilli : Chapter VI.2
gram negative cocci : Chapter VI.2
gram negative coccobacilli : Chapter VI.2
gram negative organisms : Chapter VI.5
gram negative pleomorphic rods : Chapter VI.2
gram negative rods : Chapter VI.2
gram positive bacilli : Chapter VI.2
gram positive cocci : Chapter VI.2
gram positive organisms : Chapter VI.5
gram positive rods : Chapter VI.2
gram stain : Chapter VI.2
grand mal seizure : Chapter XVIII.4
granuloma inguinale : Chapter VI.21
Graves' disease : Chapter XV.2
gray matter heterotopia : Chapter XVIII.16
gray platelet syndrome : Chapter XI.6
greenstick fracture : Chapter XIX.1
griseofulvin : Chapter VI.32
group A beta hemolytic strep (group A strep) : Chapter VI.13
group A beta hemolytic strep (group A strep) : Chapter VI.33
group A beta hemolytic strep (group A strep) : Chapter VI.34
group A strep (beta hemolytic) : Chapter VI.2
group A strep (beta hemolytic) : Chapter VI.5
group A strep (beta hemolytic) : Chapter VI.16
group A strep (beta hemolytic) : Chapter VI.18
group B strep : Chapter III.6
group B strep : Chapter VI.2
group B strep : Chapter VI.11
group B strep prophylaxis : Chapter VI.2
group B streptococcus (GBS) : Chapter III.10
group C strep : Chapter VI.2
group D strep : Chapter VI.2
growing pains : Chapter XII.3
growing skull fracture : Chapter XVIII.13
growth : Chapter I.2
growth : Chapter II.5
growth chart : Chapter I.2
growth hormone : Chapter XV.3
growth plate : Chapter XIX.1
growth spurt : Chapter XX.1
guaiac : Chapter IX.10
Guillain-Barre syndrome : Chapter XIV.3
Guillain-Barre syndrome : Chapter XVIII.7
Guillain-Barre syndrome : Chapter XVIII.15
gynecology : Chapter XX.7
Haemophilus : Chapter VI.2
Haemophilus ducreyi : Chapter VI.21
Haemophilus flu : Chapter VI.2
Haemophilus influenzae : Chapter VI.2
Haemophilus influenzae : Chapter VI.7
Haemophilus influenzae B vaccine : Chapter I.4
Haemophilus influenzae, type B : Chapter VI.2
Haemophilus influenzae, type B : Chapter VI.5
Haemophilus influenzae, type B : Chapter VI.12
Haemophilus influenzae, type B : Chapter VI.13
hallucinogens : Chapter XX.3
hamartin : Chapter XVIII.12
Hamman's sign : Chapter XIV.7
hand foot mouth disease : Chapter VI.1
hand foot mouth disease : Chapter VI.9
hand foot mouth disease : Chapter VI.22
haptoglobin : Chapter XI.1
Hashimoto thyroiditis : Chapter XV.2
HATTS : Chapter VI.21
head circumference : Chapter XVIII.1
head lice : Chapter XXI.6
Head Start : Chapter I.8
Health Care Finance Administration (HCFA) : Chapter I.11
health insurance : Chapter I.11
hearing loss : Chapter VI.6
hearing loss : Chapter VI.14
hearing screening : Chapter I.5
heart failure : Chapter VII.1
heart murmur : Chapter VII.2
heart rate : Chapter XIV.2
hectic fever : Chapter VI.3
Heimlich maneuver : Chapter VIII.6
Heiner's syndrome : Chapter VIII.7
Helicobacter pylori : Chapter IX.10
hemangioma : Chapter XXI.3
hematemesis : Chapter IX.10
hematochezia : Chapter IX.10
hematochezia : Chapter IX.11
hematochezia : Chapter IX.13
hematochezia : Chapter X.4
hematocrit : Chapter XI.1
hematogenous seeding : Chapter XIX.4
hematopoietic stem cell transplantation : Chapter V.6
hematuria : Chapter VII.5
hematuria : Chapter XIII.1
hemihypertrophy : Chapter XII.3
hemodialysis : Chapter XIII.4
hemoglobin : Chapter XI.1
hemoglobin A : Chapter XI.3
hemoglobin A1C : Chapter XV.1
hemoglobin Barts : Chapter XI.2
hemoglobin C : Chapter XI.3
hemoglobin constant springs : Chapter XI.2
hemoglobin constant springs : Chapter XI.3
hemoglobin E : Chapter XI.2
hemoglobin electrophoresis : Chapter XI.3
hemoglobin F : Chapter XI.3
hemoglobin H : Chapter XI.2
hemoglobin H disease : Chapter XI.2
hemoglobin S : Chapter XI.3
hemoglobin SC disease : Chapter XI.3
hemoglobin SS disease : Chapter XI.3
hemoglobinopathy : Chapter XI.1
hemoglobinopathy : Chapter XI.2
hemoglobinopathy : Chapter XI.3
hemoglobinuria : Chapter XI.7
hemolysis : Chapter III.2
hemolysis : Chapter XI.1
hemolytic anemia : Chapter XI.3
hemolytic transfusion reaction : Chapter XI.7
hemolytic uremic syndrome : Chapter VI.2
hemolytic uremic syndrome : Chapter XIII.5
hemolytic uremic syndrome (HUS) : Chapter IX.3
hemolytic uremic syndrome (HUS) : Chapter XI.6
hemophilia A : Chapter XI.6
hemophilia B : Chapter XI.6
hemoptysis : Chapter VIII.6
hemorrhagic disease of the newborn : Chapter II.6
hemorrhagic disease of the newborn : Chapter XI.5
hemorrhagic disease of the newborn : Chapter XI.6
hemorrhagic fever : Chapter VI.15
hemorrhagic shock : Chapter XIV.8
hemosiderin : Chapter VIII.7
hemosiderosis : Chapter VIII.7
Henderson-Hasselbalch equation : Chapter VIII.1
Henoch-Schonlein purpura : Chapter IX.2
Henoch-Schonlein purpura : Chapter IX.10
Henoch-Schonlein purpura : Chapter X.4
Henoch-Schonlein purpura : Chapter XIII.1
Henoch-Schonlein purpura : Chapter XIII.10
Henoch-Schonlein Purpura : Chapter XVI.3
hepadnavirus : Chapter VI.1
heparin induced thrombocytopenia : Chapter XI.6
hepatic amebiasis : Chapter IX.3
hepatic cirrhosis : Chapter VIII.3
hepatitis : Chapter IX.5
hepatitis : Chapter XI.7
hepatitis : Chapter XX.2
hepatitis A : Chapter IX.5
hepatitis A vaccine : Chapter I.4
hepatitis B : Chapter III.1
hepatitis B : Chapter III.11
hepatitis B : Chapter IX.5
hepatitis B immune globulin : Chapter III.11
hepatitis B prophylaxis : Chapter III.11
hepatitis B vaccine : Chapter I.4
hepatitis B vaccine : Chapter III.11
hepatitis C : Chapter IX.5
hepatitis D : Chapter IX.5
hepatitis vaccine : Chapter IX.5
hepatitis virus : Chapter VI.1
hepatocellular carcinoma : Chapter IX.5
hepatocellular necrosis : Chapter XIV.10
hepatosplenic cat scratch disease : Chapter VI.29
herd immunity : Chapter VI.10
hereditary angioedema : Chapter V.2
hereditary spherocytosis : Chapter XI.1
hereditary spherocytosis : Chapter XI.5
hermaphrodite : Chapter XIII.11
hernia : Chapter X.2
hernia : Chapter XIII.12
herniation : Chapter XVIII.13
heroin : Chapter XX.3
herpangina : Chapter VI.9
herpes encephalitis : Chapter III.11
Herpes simplex : Chapter III.10
herpes simplex : Chapter VI.1
herpes simplex : Chapter VI.15
herpes simplex : Chapter XVII.1
herpes simplex : Chapter XVII.4
herpes simplex virus (HSV) : Chapter III.11
herpes simplex virus (HSV) : Chapter VI.21
herpes virus : Chapter VI.9
herpesvirus : Chapter VI.1
heterochromia : Chapter XII.3
heterophile antibody : Chapter VI.23
heterotopia : Chapter XVIII.16
Hib : Chapter VI.13
high frequency ventilation : Chapter XIV.3
high frequency ventilation : Chapter XIV.5
high output congestive heart failure : Chapter XVIII.19
high-resolution computed tomography scan : Chapter VIII.5
hip avascular necrosis : Chapter XIX.6
hip dysplasia : Chapter XIX.6
hip pain : Chapter XIX.6
Hirschberg test : Chapter XVII.3
Hirschsprung's disease : Chapter IX.8
Hirschsprung's disease : Chapter IX.9
histamine-2 blockers : Chapter IX.6
histiocytosis-X : Chapter XXI.1
HIV : Chapter III.11
HIV : Chapter VI.1
HIV : Chapter VI.9
HIV : Chapter VI.20
HIV : Chapter VI.21
HIV : Chapter XI.6
HIV : Chapter XI.7
HIV : Chapter XX.2
HIV : Chapter XX.7
hives : Chapter V.2
hives : Chapter V.3
HIV-wasting : Chapter VI.20
HLA histocompatibility : Chapter V.6
Hodgkin's disease : Chapter XII.2
hollow viscus pain : Chapter IX.2
homatropine : Chapter XVII.5
homicide : Chapter XX.4
homocystinuria : Chapter IV.5
homosexuality : Chapter XX.6
hookworm : Chapter VI.31
hordeolum : Chapter XVII.4
HPA (hypothalamic pituitary axis) : Chapter V.4
human chorionic gonadotropin : Chapter IV.1
human diploid cell vaccine (HDCV) : Chapter VI.25
human herpes virus : Chapter VI.15
human herpes virus : Chapter VI.22
human herpes virus : Chapter VI.23
human immunodeficiency virus : Chapter VI.1
human milk : Chapter II.3
human papilloma virus (HPV) : Chapter XXI.6
human papillomavirus (HPV) : Chapter VI.21
human parvovirus : Chapter VI.22
human parvovirus : Chapter XI.3
human parvovirus : Chapter XI.4
human parvovirus B19 : Chapter III.11
human T-cell lymphotrophic virus : Chapter VI.1
Humate-P : Chapter XI.6
HUS : Chapter XIII.5
hyaline membrane disease : Chapter III.6
hydration : Chapter XI.3
hydration assessment : Chapter II.4
hydrocarbons : Chapter XIV.9
hydrocele : Chapter X.2
hydrocephalus : Chapter III.11
hydrocephalus : Chapter XVIII.9
hydrocephalus : Chapter XVIII.10
hydrocephalus : Chapter XVIII.16
hydrocortisone : Chapter V.4
hydrocortisone : Chapter XV.4
hydrocortisone : Chapter XXI.1
hydrocortisone : Chapter XXI.6
hydromorphone : Chapter XI.3
hydronephrosis : Chapter XIII.6
hydronephrosis : Chapter XIII.7
hydrops fetalis : Chapter VI.1
hydrops fetalis : Chapter XI.2
hydrops fetalis : Chapter XI.5
hydroxyapatite : Chapter I.12
hydroxyurea : Chapter XI.3
hydroxyzine : Chapter XXI.1
hygiene hypothesis : Chapter V.1
hymenoptera : Chapter XXI.5
hyper IgE syndrome : Chapter XXI.1
hyperactivity : Chapter I.10
hyperammonemia : Chapter IV.4
hyperammonemia : Chapter XVIII.17
hyperbilirubinemia : Chapter III.1
hyperbilirubinemia : Chapter III.2
hyperbilirubinemia : Chapter III.5
hypercalcemia : Chapter XV.6
hypercapnia : Chapter VIII.4
hypercarbia : Chapter XIV.3
hypercholesterolemia : Chapter XIII.2
hyperdontia : Chapter I.12
hyperglycemia : Chapter XV.1
hyperglycemia : Chapter XV.4
hyper-IgE syndrome : Chapter V.5
hyper-IgM syndrome : Chapter V.5
hyperimmune process : Chapter VIII.3
hyperinflation : Chapter VIII.6
hyperinsulinism : Chapter III.8
hyperkalemia : Chapter XIV.1
hyperkalemia : Chapter XV.4
hyperkeratosis : Chapter XXI.2
hyperkinetic disorder : Chapter I.10
hyperlipidemia : Chapter XIII.2
hypermagnesemia : Chapter XV.6
hypermenorrhea : Chapter XX.7
hypernatremia : Chapter XIV.6
hyperosmolar non-ketotic state : Chapter XV.1
hyperoxy test : Chapter III.7
hyperoxy test : Chapter VII.3
hyperparathyroidism : Chapter XV.6
hyperphosphatemia : Chapter XV.6
hyperreflexia : Chapter XVIII.2
hypersensitivity vasculitis : Chapter XVI.3
hypertension : Chapter XIII.1
hypertensive encephalopathy : Chapter XIII.1
hyperthyroidism : Chapter XV.2
hyperthyroidism : Chapter XVIII.15
hypertonic saline : Chapter XIV.2
hyperventilation : Chapter VIII.1
hyperventilation : Chapter XVIII.13
hyperviscosity : Chapter III.8
hyphema : Chapter XVII.5
hyphema : Chapter XIX.8
hypnozoite : Chapter VI.30 <